NORTHBROOK, Ill., Aug. 29, 2012 (GLOBE NEWSWIRE) -- Nanosphere, Inc., (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced that William Moffitt, Nanosphere's President and Chief Executive Officer, will present at the Rodman & Renshaw Annual Global Investment Conference taking place at the Waldorf Astoria in New York City on Monday, September 10, 2012 at 2:00 p.m. ET.
Interested investors can access a live webcast of the presentation by going to the Investor Relations tab on the Nanosphere website: www.nanosphere.us. A replay of the webcast will be made available on the Company's website for 90 days.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for detection of life threatening infections and cardiovascular diseases. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.
The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344